UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.918
NA - Nord America 4.287
EU - Europa 2.611
SA - Sud America 787
AF - Africa 110
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.732
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.144
HK - Hong Kong 3.865
SG - Singapore 1.351
IT - Italia 1.203
BR - Brasile 616
CN - Cina 497
VN - Vietnam 488
RU - Federazione Russa 297
DE - Germania 276
FR - Francia 163
BD - Bangladesh 129
TR - Turchia 118
IN - India 108
IE - Irlanda 105
FI - Finlandia 102
GB - Regno Unito 77
KR - Corea 77
AR - Argentina 76
SE - Svezia 76
UA - Ucraina 76
CA - Canada 68
AT - Austria 54
NL - Olanda 51
ID - Indonesia 46
JP - Giappone 42
ZA - Sudafrica 41
MX - Messico 37
IQ - Iraq 33
PL - Polonia 31
ES - Italia 28
CZ - Repubblica Ceca 24
EC - Ecuador 22
PK - Pakistan 20
CO - Colombia 18
SA - Arabia Saudita 17
UZ - Uzbekistan 17
CL - Cile 13
MY - Malesia 13
PH - Filippine 12
PY - Paraguay 12
JM - Giamaica 11
MA - Marocco 11
NP - Nepal 11
TN - Tunisia 11
VE - Venezuela 11
AL - Albania 10
AU - Australia 9
AZ - Azerbaigian 9
IL - Israele 9
KE - Kenya 9
LT - Lituania 9
PE - Perù 8
CR - Costa Rica 7
EG - Egitto 7
TH - Thailandia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
KG - Kirghizistan 6
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
OM - Oman 5
ET - Etiopia 4
LB - Libano 4
NZ - Nuova Zelanda 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IR - Iran 3
RO - Romania 3
AM - Armenia 2
AO - Angola 2
BJ - Benin 2
BN - Brunei Darussalam 2
BO - Bolivia 2
GM - Gambi 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
Totale 14.710
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.862
Singapore 652
San Jose 594
Milan 436
Dallas 387
Ann Arbor 377
Ashburn 317
Chandler 304
Princeton 274
Munich 192
Council Bluffs 151
Naples 139
Ho Chi Minh City 132
Lauterbourg 122
The Dalles 122
Beijing 120
Hanoi 114
Dublin 100
Los Angeles 97
Rome 95
Dong Ket 91
Izmir 91
Jacksonville 89
Moscow 75
New York 69
Wilmington 69
Houston 62
Andover 56
São Paulo 55
Pellezzano 52
Santa Clara 46
Nuremberg 45
Helsinki 44
Tokyo 37
Salerno 36
Turku 34
Vienna 33
Nanjing 32
Boardman 30
Woodbridge 30
Orem 28
Warsaw 28
Figino 25
Brno 23
Denver 23
Fisciano 23
Haiphong 22
Toronto 22
Atlanta 21
Memphis 21
Poplar 20
Fairfield 19
Amsterdam 18
Nanchang 18
Pune 18
Rio de Janeiro 18
Brooklyn 17
Chennai 17
Turin 17
Changsha 16
Columbus 16
Frankfurt am Main 16
San Francisco 16
Boston 15
Johannesburg 15
Montreal 15
Tashkent 15
Biên Hòa 14
Brasília 14
Chicago 14
Norwalk 14
Da Nang 13
Manchester 13
Shanghai 13
Baghdad 12
Mexico City 12
Mumbai 12
Paris 12
Phoenix 12
Sarno 12
Seattle 12
Bologna 11
Buffalo 11
Lappeenranta 11
Quito 11
Seoul 11
Stockholm 11
Belo Horizonte 10
Jakarta 10
Baku 9
Cape Town 9
Curitiba 9
Goiânia 9
Tel Aviv 9
Washington 9
Baronissi 8
Campinas 8
Charlotte 8
Guarulhos 8
Istanbul 8
Totale 10.544
Salva come PNG Salva come JPEG
Nome #
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 610
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 610
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series 539
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 513
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 490
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 422
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 332
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review 255
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 254
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 250
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 199
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 197
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 188
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 153
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 152
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 148
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 147
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 140
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 139
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 139
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 138
Abstract 3639: Combinatorial therapy for triple negative breast cancer 138
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 137
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in advanced cancer patients treated with anti-PD-1/PD-L1 therapy 135
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 133
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 132
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 128
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 127
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 119
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 119
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 118
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 117
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 113
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 112
Blocking the formation of radiation-induced breast cancer stem cells 111
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 110
Counteracting resistance to treatments in solid tumors. 109
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 109
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 109
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 108
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 107
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 105
Multidisciplinary approach to patient with malignant melanoma 105
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 103
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 103
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 103
PD-L1 Dysregulation in COVID-19 Patients 102
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 100
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 99
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 99
Epigenetic control of gene expression: Potential implications for cancer treatment 97
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 96
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 95
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 95
Surgical Treatment, Rehabilitative Approaches and Functioning Assessment for Patients Affected by Breast Cancer-Related Lymphedema: A Comprehensive Review 94
Clinical and genetic drivers of oligo-metastatic disease in colon cancer 93
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 93
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 92
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 92
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 91
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 89
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 89
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 88
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 88
Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice 87
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 87
Harnessing host innate immunity may combat acquired resistance to BRAFi 85
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 84
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 83
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 83
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 82
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 81
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 81
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 80
Emerging BRAF inhibitors for melanoma 80
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis 78
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives 78
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 78
Testing egfr with idylla on cytological specimens of lung cancer: A review 77
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 77
Melanoma initiating cells: where do we stand? 76
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 76
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 75
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 74
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 73
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 72
Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know 71
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 71
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 71
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 69
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 69
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 68
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 67
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 67
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 63
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 62
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 62
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 62
Tumor mutational burden modulates the prognostic effect of RAS mutations in metastatic colon cancer: mechanistic insights and genotype-phenotype correlations 61
Genetic evolution of T-cell resistance in the course of melanoma progression 60
Totale 13.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022462 7 0 2 1 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.792 44 17 28 66 90 195 322 138 335 141 198 218
2025/202610.072 792 2.229 1.769 681 741 432 977 233 488 646 292 792
2026/202782 82 0 0 0 0 0 0 0 0 0 0 0
Totale 15.027